Viburkol suppositories No. 12

Instructions for Viburkol suppositories No. 12

Composition

active substances: 1 suppository of 1.1 g contains: Atropa bella-donna D2 - 1.1 mg, Calcium carbonicum Hahnemanni D8 - 4.4 mg, Matricaria recutita D1 - 1.1 mg, Plantago major D3 - 1.1 mg, Pulsatilla pratensis D2 - 2.2 mg, Solanum dulcamara D4 - 1.1 mg;

excipient: solid fat.

Dosage form

Suppositories.

Main physical and chemical properties: suppositories of torpedo shape, with a smooth surface, from white to yellow-white (ivory color), with a weak characteristic (not rancid) odor. During storage, the formation of a white fatty coating on the surface of the suppository is allowed.

Pharmacotherapeutic group

A complex homeopathic preparation.

Pharmacological properties

A drug with anti-inflammatory, analgesic, sedative, detoxification, and antispasmodic effects, which is based on activating the body's defenses and normalizing impaired functions due to substances of plant and mineral origin that are part of the drug.

Indication

Inflammatory processes of various localization: ENT organs, genitals in women; infectious diseases (ARI, acute diseases of the upper respiratory tract, infectious and inflammatory processes of internal organs), nervous excitement, state of convulsive readiness.

Contraindication

Hypersensitivity to any component of the drug, to chamomile or to other plants of the Asteraceae family.

Interaction with other medicinal products and other types of interactions

The drug is compatible with other medications.

Application features

If symptoms persist or worsen, you should consult a doctor.

Use during pregnancy or breastfeeding

The question of the appropriateness of using the drug for pregnant and breastfeeding women is decided by the doctor individually, taking into account the benefit/risk.

Ability to influence reaction speed when driving vehicles or other mechanisms

Cases of exposure are unknown.

Method of administration and doses

The drug should be used rectally.

The recommended dose for adults and children aged 6 months and older in acute conditions is 1 suppository 3-5 times a day; when the condition improves, 2-3 times a day.

For newborns (from the first day of life) up to 6 months – 1 suppository, twice a day.

The duration of treatment and frequency of use is determined by the doctor depending on the nature and course of the disease. Usually the course of treatment is 3-14 days.

Children

The drug is recommended for use in children from birth.

Overdose

It was not noted.

Adverse reactions: In very rare cases, allergic reactions are possible, including skin rashes and itching.

Expiration date

3 years.

The expiration date determines the use of the drug until the last day of the month.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 °C, out of the reach of children.

Packaging

12 (6 x 2) suppositories in a blister made of polyvinyl chloride/polyethylene film, in a cardboard box.

Vacation category

Without a prescription.

Producer

Biologische Heilmittel Heel GmbH.

Location of the manufacturer and its business address

Dr. Reckeweg-Str. 2-4, 76532 Baden-Baden, Germany/Dr. Reckeweg-Str. 2-4, 76532 Baden-Baden, Germany.